150 related articles for article (PubMed ID: 20564150)
1. Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinoma.
Chua TC; Chu F; Butler SP; Quinn RJ; Glenn D; Liauw W; Morris DL
Cancer; 2010 Sep; 116(17):4069-77. PubMed ID: 20564150
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
Lau WY; Lai EC; Leung TW; Yu SC
Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
Boucher E; Garin E; Guylligomarc'h A; Olivié D; Boudjema K; Raoul JL
Radiother Oncol; 2007 Jan; 82(1):76-82. PubMed ID: 17141900
[TBL] [Abstract][Full Text] [Related]
4. Treatment of unresectable hepatocellular carcinoma with radiolabelled lipiodol.
Kanhere HA; Leopardi LN; Fischer L; Kitchener MI; Maddern GJ
ANZ J Surg; 2008 May; 78(5):371-6. PubMed ID: 18380736
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
Boucher E; Bouguen G; Garin E; Guillygomarch A; Boudjema K; Raoul JL
J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267
[TBL] [Abstract][Full Text] [Related]
6. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma.
Boucher E; Corbinais S; Rolland Y; Bourguet P; Guyader D; Boudjema K; Meunier B; Raoul JL
Hepatology; 2003 Nov; 38(5):1237-41. PubMed ID: 14578862
[TBL] [Abstract][Full Text] [Related]
8. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901
[TBL] [Abstract][Full Text] [Related]
10. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol.
Raoul JL; Messner M; Boucher E; Bretagne JF; Campion JP; Boudjema K
Br J Surg; 2003 Nov; 90(11):1379-83. PubMed ID: 14598418
[TBL] [Abstract][Full Text] [Related]
11. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
Guiu B; Colin C; Cercueil JP; Loffroy R; Guiu S; Ferrant E; Jouve JL; Bonnetain F; Boulin M; Ghiringhelli F; Minello A; Hillon P; Bedenne L; Krause D; Chauffert B
Am J Clin Oncol; 2009 Jun; 32(3):238-44. PubMed ID: 19349854
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
[TBL] [Abstract][Full Text] [Related]
14. Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients.
Dumortier J; Chapuis F; Borson O; Davril B; Scoazec JY; Poncet G; Henry L; Boillot O; Mion F; Berger F; Partensky C; Paliard P; Valette PJ
Dig Liver Dis; 2006 Feb; 38(2):125-33. PubMed ID: 16389002
[TBL] [Abstract][Full Text] [Related]
15. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
16. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
Raoul JL; Boucher E; Roland V; Garin E
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study.
Bernal P; Raoul JL; Vidmar G; Sereegotov E; Sundram FX; Kumar A; Jeong JM; Pusuwan P; Divgi C; Zanzonico P; Stare J; Buscombe J; Minh CT; Saw MM; Chen S; Ogbac R; Padhy AK
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1448-55. PubMed ID: 17692473
[TBL] [Abstract][Full Text] [Related]
18. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
Novell JR; Hilson AJ
J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
[No Abstract] [Full Text] [Related]
19. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383).
Rai R; Rai S
Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642
[No Abstract] [Full Text] [Related]
20. Treatment of unresectable hepatocellular carcinoma: targeted therapies using iodized oil.
Bhattacharya S; Dusheiko GM
Princess Takamatsu Symp; 1995; 25():253-64. PubMed ID: 8875631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
